Skip to main content

Blend Labs Inc

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

BLND$1.08+9.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

On August 12, 2024, Timothy J. Mayopoulos, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 273,374 shares of our Class A common stock, with the exact number of shares to be sold pursuant to Mr. Mayopoulos’s trading arrangement to be determined based on market prices of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 9, 2025, or earlier if all transactions under the trading arrangement are completed.

On August 22, 2024, Nima Ghamsari, our Head of Blend, Co-Founder, and Chair of our board of directors, terminated his previously reported Rule 10b5-1 trading arrangement previously adopted on June 14, 2024. The terminated trading plan provided for the potential sale of up to an aggregate of 2,400,000 shares of our Class A common stock, plus sales of shares of our Class A common stock issued upon the vesting of restricted stock units intended to generate anaggregate of approximately $450,000. As of the termination date, no shares of our Class A common stock were sold under the trading arrangement.

On September 12, 2024, Brian Kneafsey, our Head of Revenue, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 360,000 shares of our Class A common stock, with the exact number of shares to be sold pursuant to Mr. Kneafsey’s trading arrangement to be determined based on market prices of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until June 1, 2025, or earlier if all transactions under the trading arrangement are completed.

No other officers or directors, as defined in Rule 16a-1(f), adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408, during the last fiscal quarter.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.